Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Denning

Showing results (411-420 of 466) with videos related to

Pageof 47
Sort By:
Journal of Clinical Microbiology|April 9, 2010
Molecular detection and identification of zygomycetes species from paraffin-embedded tissues in a murine model of disseminated zygomycosis: a collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) evaluationEric Dannaoui, Patrick Schwarz, Michal Slany, et al.
Open Forum Infectious Diseases|July 20, 2022
Cryptococcal and <i>Histoplasma</i> Antigen Screening Among People With Human Immunodeficiency Virus in Ghana and Comparative Analysis of OIDx <i>Histoplasma</i> Lateral Flow Assay and IMMY <i>Histoplasma</i> Enzyme ImmunoassayBright K Ocansey, Benjamin Otoo, Isabella Asamoah, et al.
Open Forum Infectious Diseases|July 24, 2024
The Impact of the Fungal Priority Pathogens List on Medical Mycology: A Northern European PerspectiveMaiken Cavling Arendrup, Darius Armstrong-James, Andrew M Borman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 8, 2008
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of AmericaThomas J Walsh, Elias J Anaissie, David W Denning, et al.
Mucosal Immunology|November 21, 2025
Activation status of airway immune cells is a defining feature of severe asthma, regardless of fungal sensitisationEmily L Plumpton, Stefano A P Colombo, Matthew Steward, et al.
Journal of Clinical Microbiology|March 4, 2011
Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assayPhilippe M Hauser, Jacques Bille, Cornelia Lass-Flörl, et al.
Medical Mycology|December 28, 2023
The Nairobi Declaration 2023: A commitment to address deadly yet neglected fungal diseases in AfricaIriagbonse I Osaigbovo, Nelesh P Govender, Alexander M Jordan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2007
Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo signReginald E Greene, Haran T Schlamm, Jörg-W Oestmann, et al.
The European Respiratory Journal|July 25, 2020
Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosisDarius Armstrong-James, Jonathan Youngs, Tihana Bicanic, et al.
The Lancet. Infectious Diseases|November 13, 2025
British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases: 2025 updateSilke Schelenz, Alireza Abdolrasouli, Darius Armstrong-James, et al.
Pageof 47

Showing results (411-420 of 466) with videos related to

Sort By:
Pageof 47
Journal of Clinical Microbiology|April 9, 2010
Molecular detection and identification of zygomycetes species from paraffin-embedded tissues in a murine model of disseminated zygomycosis: a collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) evaluationEric Dannaoui, Patrick Schwarz, Michal Slany, et al.
Open Forum Infectious Diseases|July 20, 2022
Cryptococcal and <i>Histoplasma</i> Antigen Screening Among People With Human Immunodeficiency Virus in Ghana and Comparative Analysis of OIDx <i>Histoplasma</i> Lateral Flow Assay and IMMY <i>Histoplasma</i> Enzyme ImmunoassayBright K Ocansey, Benjamin Otoo, Isabella Asamoah, et al.
Open Forum Infectious Diseases|July 24, 2024
The Impact of the Fungal Priority Pathogens List on Medical Mycology: A Northern European PerspectiveMaiken Cavling Arendrup, Darius Armstrong-James, Andrew M Borman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 8, 2008
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of AmericaThomas J Walsh, Elias J Anaissie, David W Denning, et al.
Mucosal Immunology|November 21, 2025
Activation status of airway immune cells is a defining feature of severe asthma, regardless of fungal sensitisationEmily L Plumpton, Stefano A P Colombo, Matthew Steward, et al.
Journal of Clinical Microbiology|March 4, 2011
Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assayPhilippe M Hauser, Jacques Bille, Cornelia Lass-Flörl, et al.
Medical Mycology|December 28, 2023
The Nairobi Declaration 2023: A commitment to address deadly yet neglected fungal diseases in AfricaIriagbonse I Osaigbovo, Nelesh P Govender, Alexander M Jordan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2007
Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo signReginald E Greene, Haran T Schlamm, Jörg-W Oestmann, et al.
The European Respiratory Journal|July 25, 2020
Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosisDarius Armstrong-James, Jonathan Youngs, Tihana Bicanic, et al.
The Lancet. Infectious Diseases|November 13, 2025
British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases: 2025 updateSilke Schelenz, Alireza Abdolrasouli, Darius Armstrong-James, et al.
Pageof 47